Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)

导出原文传递

翻译打印收藏纠错

作者： Orgel, Ryan ^[1] ; Wojdyla, Daniel ^[2] ; Huberman, David ^[3] ; Halperin, Jonathan L. ^[4] ; Breithardt, Guenter ^[5] ; Singer, Daniel E. ^[6] ; Fox, Keith A. A. ^[7] ; Hankey, Graeme J. ^[8] ; Mahaffey, Kenneth W. ; Jones, W. Schuyler ; Patel, Manesh R.

作者单位： Hosp Univ Munster, Dept Cardiovasc Med, Munster, Germany ^[1] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA ^[2] Univ Edinburgh, Edinburgh, Scotland ^[3] Massachusetts Gen Hosp, Boston, MA 02114 USA ^[4] Mt Sinai Med Ctr, New York, NY 10029 USA ^[5] Univ Western Australia, Sch Med & Pharmacol, Crawley, Australia ^[6] North Carolina State Univ, Dept Stat, Raleigh, NC USA ^[7] Stanford Univ, Sch Med, Stanford, CA 94305 USA ^[8]

发布时间 2018-02-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交